ATE59295T1 - Prazosin-pirbuterol-mischung zur bronchendilatation. - Google Patents

Prazosin-pirbuterol-mischung zur bronchendilatation.

Info

Publication number
ATE59295T1
ATE59295T1 AT86308544T AT86308544T ATE59295T1 AT E59295 T1 ATE59295 T1 AT E59295T1 AT 86308544 T AT86308544 T AT 86308544T AT 86308544 T AT86308544 T AT 86308544T AT E59295 T1 ATE59295 T1 AT E59295T1
Authority
AT
Austria
Prior art keywords
pirbuterol
prazosin
bronchodilating
blend
pharmaceutically acceptable
Prior art date
Application number
AT86308544T
Other languages
German (de)
English (en)
Inventor
Craig Allan Paul Dance Saxton
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE59295T1 publication Critical patent/ATE59295T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT86308544T 1985-11-06 1986-11-03 Prazosin-pirbuterol-mischung zur bronchendilatation. ATE59295T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/795,689 US4601897A (en) 1985-11-06 1985-11-06 Prazosin-pirbuterol combination for bronchodilation
EP86308544A EP0222575B1 (en) 1985-11-06 1986-11-03 Prazosin-pirbuterol combination for bronchodilation

Publications (1)

Publication Number Publication Date
ATE59295T1 true ATE59295T1 (de) 1991-01-15

Family

ID=25166193

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86308544T ATE59295T1 (de) 1985-11-06 1986-11-03 Prazosin-pirbuterol-mischung zur bronchendilatation.

Country Status (14)

Country Link
US (1) US4601897A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0222575B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS62135424A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE59295T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU567018B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1284107C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3676640D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK527186A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2036174T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3001420T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE59327B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL80476A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ218175A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA868427B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868182A (en) * 1986-11-05 1989-09-19 Merrell Dow Pharmaceuticals Inc. Enhancement of prazosin
ZA878182B (en) * 1986-11-05 1988-05-02 Merrell Dow Pharmaceuticals Inc. Enhancement of prazosin
US5110927A (en) * 1987-12-31 1992-05-05 The United States Of America As Represented By The Department Of Health And Human Services Prazosin analog with increased selectivity and duration of action
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5776434A (en) 1988-12-06 1998-07-07 Riker Laboratories, Inc. Medicinal aerosol formulations
US6048857A (en) * 1989-10-17 2000-04-11 Ellinwood, Jr.; Everett H. Dosing method of administering medicaments via inhalation administration
US5439670A (en) * 1989-11-28 1995-08-08 Riker Laboratories, Inc. Medicinal aerosol formulations
US5503869A (en) * 1994-10-21 1996-04-02 Glaxo Wellcome Inc. Process for forming medicament carrier for dry powder inhalator
JP2008535924A (ja) * 2005-04-12 2008-09-04 エラン ファーマ インターナショナル リミテッド ナノ粒子キナゾリン誘導体製剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3517005A (en) * 1967-10-26 1970-06-23 Pfizer & Co C Certain 2- and 4-substituted quinazolines
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3723434A (en) * 1970-07-17 1973-03-27 Pfizer Piperazino isoquinoline bronchodilators
US3786160A (en) * 1971-02-16 1974-01-15 Pfizer Use of 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)-pyridines as bronchodilators
US3700681A (en) * 1971-02-16 1972-10-24 Pfizer 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride
GB1591490A (en) * 1977-08-04 1981-06-24 Abbott Lab 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
US4175128A (en) * 1979-01-03 1979-11-20 Pfizer Inc. Method for treating congestive heart failure
FI67699C (fi) * 1979-01-31 1985-05-10 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
DE3235565A1 (de) * 1982-09-25 1984-03-29 Boehringer Ingelheim KG, 6507 Ingelheim Piperidinderivate, ihre herstellung und verwendung

Also Published As

Publication number Publication date
IE862911L (en) 1987-05-06
AU567018B2 (en) 1987-11-05
JPH0524890B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-04-09
EP0222575B1 (en) 1990-12-27
US4601897A (en) 1986-07-22
JPS62135424A (ja) 1987-06-18
NZ218175A (en) 1989-04-26
EP0222575A1 (en) 1987-05-20
DK527186D0 (da) 1986-11-05
GR3001420T3 (en) 1992-09-25
DK527186A (da) 1987-05-07
IL80476A0 (en) 1987-02-27
ZA868427B (en) 1988-06-29
AU6483286A (en) 1987-05-21
DE3676640D1 (de) 1991-02-07
ES2036174T3 (es) 1993-05-16
CA1284107C (en) 1991-05-14
IE59327B1 (en) 1994-02-09

Similar Documents

Publication Publication Date Title
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE69430440D1 (de) Zusammensetzungen zur inhibition von retroviraler verbreitung, die 2',3'-dideoxy-inosin und hydroxyharnstoff enthalten
ATE25525T1 (de) N-glycosylierte carbonsaeureamid-derivate, verfahren zu ihrer herstellung sowie ihre verwendung zur beeinflussung der koerpereigenen abwehr.
DE3855113D1 (de) Verwendung von Buspiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung der Alkoholsucht
UA26403A (uk) Похідhі n-заміщеhого 4-феhіл-4-піперидиhкарбоксаміду та їх фармацевтичhо прийhятhі солі, що проявляють аhестезувальhу та аhальгезувальhу дію, спосіб їх одержаhhя та фармацевтичhа композиція
HU913010D0 (en) Method for producing inhibitors of calcium ingestion
DE69802113D1 (de) Zusammensetzungen zur erhöhung der konzentration und/oder beweglichkeit von samenzellen in menschen
ATE55695T1 (de) Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
GR80951B (en) Pharmaceutical compositions and method for preparing phosphatidylserine compositions useful in treating central nervous system disorders without effects on blood coagulation
ATE59295T1 (de) Prazosin-pirbuterol-mischung zur bronchendilatation.
ES8400742A1 (es) Procedimiento de preparacion de las dibenzooxepinas sustituidas y de sus sales de adicion con un acido mineral u organi-co.
DE3361990D1 (en) Alkylene-bridged guanidino-thiazole derivatives, method for their preparation and their use as medicaments
DE3063525D1 (en) Process for the preparation of phosphono-hydroxy-acetic acid and salts thereof and autiviral compositions containing them
IT1197516B (it) Derivati teofillinmetilanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono
HUT59100A (en) Process for producing acetylene derivatives of calcium-absorbtion inhibiting activity and pharmaceutical compositions containing them
DK0541726T3 (da) Vækstfaktorsammensætninger, fremstilling og anvendelse
ATE115586T1 (de) Naphthalen- und tetrahydronaphthalen-gem- diphosphonat-derivate.
ATE70444T1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
EP0181636A3 (en) 2 5-cyanopyridine-2-diazohydroxide, basic salts and methods for production and use
ES402468A1 (es) Un procedimiento para la preparacion de vincamina y compuestos semejantes